Atlas Trials

Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer

Clinical trial NCT01189370 · COMPLETED

Trial details

NCT number
NCT01189370
Sponsor
University of Kansas Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Cancer
Start date
2008-06-01
Primary completion
2015-04-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.